During the past decade, Langlade Hospital and Cancer Center conducted 81 clinical trials. In the 10-year time frame, 81 clinical trials started and 52 clinical trials were completed, i.e. on average, 64.2% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 36 clinical trials were completed. i.e. 102.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Langlade Hospital and Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 58 trials, followed by "SWOG Cancer Research Network" with 28 trials sponsored, "Alliance for Clinical Trials in Oncology" with 13 trials sponsored, "NRG Oncology" with 13 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 13 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Langlade Hospital and Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 69 trials as a collaborator, "NRG Oncology" with 18 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "Radiation Therapy Oncology Group" with 4 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Langlade Hospital and Cancer Center" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Invasive Breast Carcinoma" (7 trials), "Stage IV Lung Cancer AJCC v8" (7 trials) and "Recurrent Breast Carcinoma" (6 trials). Many other conditions were trialed in "Langlade Hospital and Cancer Center" in a lesser frequency.

Most popular intervention types in "Langlade Hospital and Cancer Center" are "Drug" (102 trials), "Other" (85 trials), "Biological" (58 trials), "Radiation" (31 trials) and "Procedure" (29 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (42 trials), "Quality-of-Life Assessment" (41 trials), "Questionnaire Administration" (20 trials), "Biospecimen Collection" (17 trials) and "Computed Tomography" (17 trials). Other intervention names were less common.

The vast majority of trials in "Langlade Hospital and Cancer Center" are 102 trials for "All" genders, 17 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Langlade Hospital and Cancer Center". undefined are not yet recruiting, 33 are recruiting, 62 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Langlade Hospital and Cancer Center, 3 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Langlade Hospital and Cancer Center, 1 "Phase 1" clinical trials were conducted, 52 "Phase 2" clinical trials and 87 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".